Researchers are working on extremely-extensive-acting GLP-one analogs which could call for dosing just once per month and even less usually. These prolonged-release versions could allow it to be even simpler to stick with having GLP-1s.  Semaglutide and tirzepatide are currently the preferred selections for weight-loss and type two diabetes. Lira